Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00371670 · ClinicalTrials.gov registry record · Phase 2
Safety/Efficacy of Balicatib (AAE581) in Adults With Osteoarthritis of the Knee
A Phase 2 study of Knee Osteoarthritis, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 223
- Enrollment target
- 2
- Study locations
NCT00371670 is a Phase 2 study of Knee Osteoarthritis that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 223 participants, below the 302-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (26% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00371670, a Phase 2 study of Knee Osteoarthritis, has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 223 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will test efficacy and safety of AAE581 compared to placebo in limiting cartilage loss in patients with painful knee osteoarthritis which is confirmed by X-ray
Conditions Studied
Interventions
- DRUG balicatib (AAE581)
Study Locations (2)
Alabama
- Pinnacle Research Group - Anniston
Other
- Novartis - Nuremberg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2004-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00371670
The ClinicalTrials.gov registry entry for NCT00371670 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (26% lower). The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which balicatib (AAE581) is the first listed.
NCT00371670 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Other.
Frequently Asked Questions
What is clinical trial NCT00371670 about?
NCT00371670 is a clinical study titled "Safety/Efficacy of Balicatib (AAE581) in Adults With Osteoarthritis of the Knee". This study will test efficacy and safety of AAE581 compared to placebo in limiting cartilage loss in patients with painful knee osteoarthritis which is confirmed by X-ray
What is the current status of trial NCT00371670?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 223 participants. The study started on 2004-12.
What conditions does trial NCT00371670 study?
This clinical trial studies the following conditions: Knee Osteoarthritis.
What interventions are being tested in trial NCT00371670?
The interventions under investigation include: balicatib (AAE581) (DRUG).
Who is sponsoring clinical trial NCT00371670?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00371670 being conducted?
This trial has 2 study locations across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intra-articular Platelet-Rich Plasma Compared With Viscosupplementation in the Treatment of Knee Osteoarthritis
RECRUITING · Phase 2
-
Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA
RECRUITING · Phase 2
-
A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis
RECRUITING · Phase 2
-
Genicular Artery Embolization for Reducing Pain in Medically Refractory Symptomatic Knee Osteoarthritis
RECRUITING · Phase 2
-
A Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Moderate Patello-Femoral Osteoarthritis Involving Both Knees
COMPLETED · Phase 2
-
Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the Knee
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.